Mast cell activation by glia maturation factor, 1-methyl-4-phenylpyridinium and α-synuclein: implications for Parkinson's disease

被引：0
|
作者：
Zaheer, Asgar [1 ,2 ]
Kempuraj, Duraisamy [1 ]
Khan, Mohammad [1 ]
Javed, Hayate [1 ]
Zaheer, Smita [1 ]
机构：
[1] Univ Iowa, Iowa City, IA USA
[2] Neurol VAHCS, Iowa City, IA USA
来源：
FASEB JOURNAL | 2014年 / 28卷 / 01期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
596.5
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Dopaminergic Toxin 1-Methyl-4-Phenylpyridinium, Proteins α-Synuclein and Glia Maturation Factor Activate Mast Cells and Release Inflammatory Mediators
    Kempuraj, Duraisamy
    Thangavel, Ramasamy
    Yang, Evert
    Pattani, Sagar
    Zaheer, Smita
    Santillan, Donna A.
    Santillan, Mark K.
    Zaheer, Asgar
    PLOS ONE, 2015, 10 (08):
  • [2] The Parkinsonian toxin 1-methyl-4-phenylpyridinium (MPP plus ), and proteins α-synuclein and glia maturation factor (GMF) activate mast cells and release proinflammatory mediators
    Kempuraj, D.
    Ramasamy, T.
    Zaheer, S.
    Santillan, D. A.
    Santillan, M. K.
    Zaheer, A.
    MOVEMENT DISORDERS, 2015, 30 : S274 - S275
  • [3] Deficiency of glia maturation factor suppresses 1-methyl-4-phenylpyridinium induced toxicity in primary cultures of mouse astrocytes
    Khan, Mohammad M.
    Javed, Hayate
    Zaheer, Asgar
    FASEB JOURNAL, 2013, 27
  • [4] SUPPRESSION OF GLIA MATURATION FACTOR EXPRESSION PREVENTS 1-METHYL-4-PHENYLPYRIDINIUM (MPP+)-INDUCED LOSS OF MESENCEPHALIC DOPAMINERGIC NEURONS
    Khan, M. M.
    Zaheer, S.
    Nehman, J.
    Zaheer, A.
    NEUROSCIENCE, 2014, 277 : 196 - 205
  • [5] DLP1-dependent mitochondrial fragmentation mediates 1-methyl-4-phenylpyridinium toxicity in neurons: implications for Parkinson's disease
    Wang, Xinglong
    Su, Bo
    Liu, Wanhong
    He, Xiaohua
    Gao, Yuan
    Castellani, Rudy J.
    Perry, George
    Smith, Mark A.
    Zhu, Xiongwei
    AGING CELL, 2011, 10 (05) : 807 - 823
  • [6] Rat model of Parkinson's disease:: Chronic central delivery of 1-methyl-4-phenylpyridinium (MPP+)
    Yazdani, U.
    German, D. C.
    Liang, C. -L.
    Manzino, L.
    Sonsalla, P. K.
    Zeevalk, G. D.
    EXPERIMENTAL NEUROLOGY, 2006, 200 (01) : 172 - 183
  • [7] Bioenergetic Remodeling Induced by 1-methyl-4-phenylpyridinium (MPP+) in Dopaminergic N27 cells: Implications for Parkinson's Disease
    Dranka, Brian P.
    Zielonka, Jacek
    Kanthasamy, Anumantha G.
    Kalyanaraman, B.
    FREE RADICAL BIOLOGY AND MEDICINE, 2010, 49 : S154 - S155
  • [8] Neuroprotective effect of Buddleja cordata methanolic extract in the 1-methyl-4-phenylpyridinium Parkinson’s disease rat model
    Gabriela Pérez-Barrón
    José Guillermo Ávila-Acevedo
    Ana María García-Bores
    Sergio Montes
    Sara García-Jiménez
    Ismael León-Rivera
    Moisés Rubio-Osornio
    Antonio Monroy-Noyola
    Journal of Natural Medicines, 2015, 69 : 86 - 93
  • [9] Neuroprotective effect of Buddleja cordata methanolic extract in the 1-methyl-4-phenylpyridinium Parkinson's disease rat model
    Perez-Barron, Gabriela
    Guillermo Avila-Acevedo, Jose
    Maria Garcia-Bores, Ana
    Montes, Sergio
    Garcia-Jimenez, Sara
    Leon-Rivera, Ismael
    Rubio-Osornio, Moises
    Monroy-Noyola, Antonio
    JOURNAL OF NATURAL MEDICINES, 2015, 69 (01) : 86 - 93
  • [10] Neuroprotective cytokines repress PUMA induction in the 1-methyl-4-phenylpyridinium (MPP+) model of Parkinson's disease
    Kook, Yeon-Hee
    Ka, Minhan
    Um, Moonkyoung
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2011, 411 (02) : 370 - 374
12345